The main issue addressed by the project is that the steps required for the application of radioligand therapies must be actively monitored and performed on time to ensure that the patient receives therapy promptly. This ensures the best possible treatment outcomes and helps avoid losses due to the untimely use of drugs intended for therapy—radiopharmaceuticals.

This project aims to develop a digital Integrated Theranostic Oncology Platform (ITOP), which will analyze the patient's clinical information, initial and follow-up examination data, and the course of treatment.

The use of this platform would reduce the administrative workload of doctors and other medical staff when planning and monitoring the course of radioligand therapies, and ensure the efficient use of healthcare infrastructure resources.

The total value of the project is EUR 303,290. The project is co-financed by the European Union—EUR 200,000 is allocated from EU funds. The implementation period of the project activities is from June 25, 2025, to October 25, 2026.

More information: www.esinvesticijos.lt